400,000 cumulative downloads and 180,000 monthly active users (MAU) in just 10 months since launch
Vespexx, a global femtech company and subsidiary of in vitro diagnostics specialist Sugentech, announced on January 10 that it received the AI Wellness 111 Innovation Award at CES 2025, the world's largest consumer electronics and technology expo.
The award officially recognized Vespexx for opening a new category by combining couples-oriented collaboration tools with AI-powered health insights.
Vespexx is pioneering a new field it calls "relational wellness" — the idea that couples, whether dating or married, can enjoy healthier lives together. The company's vision goes beyond building a simple calendar app; it aims to provide a comprehensive AI-driven solution that helps modern couples manage their schedules, health, and relationships all in one place.
Vespexx's flagship service, Signaling, integrates schedule management, health tracking, and lifestyle sharing into a single intelligent calendar-based platform. The app has generated explosive traction among couples in their 20s and 30s worldwide, reaching 400,000 cumulative downloads and 180,000 monthly active users within just 10 months of launch.
Through its participation in CES, Vespexx is solidifying its blueprint for global expansion across North America, East Asia, and beyond.
Scarlett Joowon Jung, Co-CEO of Vespexx, stated: "We are ready to take the technology we've proven in Korea and test it on the global stage. Our goal is to reach 1 million global users and 500,000 monthly active users by 2025."
One of the key reasons Vespexx has attracted significant attention is its expansion into an AI-based digital wellness platform powered by precise analysis of health data, including female hormone metrics. Grounded in the insight that more than 60% of femtech market issues are actually managed within the context of a couple's relationship, the company is focusing not just on women's health solutions, but on relationship technology that encompasses both partners.
Vespexx's earlier apps, "Surearlyz" and "Surearly Smart," earned strong user praise for supporting ovulation test analysis and hormone diagnostics. Combined with Signaling's comprehensive management of couple schedules and health indicators, the company has firmly established its image as an essential wellness partner for modern couples.
Building on the momentum of its CES AI Wellness 111 Innovation Award, Vespexx plans to aggressively target key global markets including the United States and Japan.
Co-CEO Jungg added: "At CES, we witnessed an overwhelmingly enthusiastic response from attendees to our technology. Going forward, we will continue to build on Signaling's foundation to deliver even more advanced AI digital healthcare capabilities and highly personalized services."
Original Article By:
Yakup News | Hyukjin Kwon| hjkwon@yakup.com
The content has been translated and edited from the original article.
